Literature DB >> 16554869

Leprosy disease in Nepal : knowledge and non-compliance of patients.

S C Chalise1.   

Abstract

Non-compliance among leprosy patients has always been a problem in Nepal. Many researches on drug compliance has indicated that if a patient understands well about his /her disease and its treatment, he /she is more likely to be motivated to take the whole prescribed course of treatment properly. It is widely believed that the understanding and behavior of patients in relation to drug compliance are largely influenced by their socio-economic condition and level of knowledge. In order to determine the socio-economic characteristics of non-compliant leprosy patients and their level of knowledge of leprosy disease and treatment, a non-intervention study was carried-out in Dhanusha - a high prevalent district in Nepal bordering India. A total of 57 non-compliant leprosy cases were selected using systematic sampling method on the basis of available clinical records and an interview-schedule was used for data collection. The result shows that the majority of non-compliant cases were illiterate, laborers by occupation and from poor economic class family background (73.7%). Data revealed that majority did not understand the cause of the disease and were not aware of the duration of treatment. It was interesting to note that an overwhelming majority (94.7%) were having strong belief that the disappearance of sign/symptoms was the only meaning of the "cure of leprosy disease". In view of this, it is strongly recommended that the patient education and counseling, public/community awareness program should be improved and further strengthened. A socio-economic rehabilitation program with vocational/trade training to leprosy patients or their family members should be arranged to up-lift their socio-economic status.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16554869

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  6 in total

1.  Interruption and defaulting of multidrug therapy against leprosy: population-based study in Brazil's Savannah Region.

Authors:  Jorg Heukelbach; Olga André Chichava; Alexcian Rodrigues de Oliveira; Kathrin Häfner; Friederike Walther; Carlos Henrique Morais de Alencar; Alberto Novaes Ramos; Adriana Cavalcante Ferreira; Liana Ariza
Journal:  PLoS Negl Trop Dis       Date:  2011-05-03

2.  Understanding non-compliance with WHO-multidrug therapy among leprosy patients in Assam, India.

Authors:  Sumit Kar; Ranabir Pal; Dharamvir Ranajan Bharati
Journal:  J Neurosci Rural Pract       Date:  2010-01

3.  Leprosy treatment dropout: a systematic review.

Authors:  Régio José Santiago Girão; Nara Lívia Rezende Soares; Juliana Viana Pinheiro; Giuliano da Paz Oliveira; Sionara Melo Figueiredo de Carvalho; Luiz Carlos de Abreu; Vitor E Valenti; Fernando Luiz Affonso Fonseca
Journal:  Int Arch Med       Date:  2013-08-30

4.  Community knowledge, attitude, and perceived stigma of leprosy amongst community members living in Dhanusha and Parsa districts of Southern Central Nepal.

Authors:  Rakesh Singh; Babita Singh; Sharika Mahato
Journal:  PLoS Negl Trop Dis       Date:  2019-01-11

5.  "If you will counsel properly with love, they will listen": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal.

Authors:  Jorge César Correia; Alain Golay; Sarah Lachat; Suman Bahadur Singh; Varsha Manandhar; Nilambar Jha; François Chappuis; David Beran
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

6.  Geographic and socioeconomic factors associated with leprosy treatment default: An analysis from the 100 Million Brazilian Cohort.

Authors:  Kaio Vinicius Freitas de Andrade; Joilda Silva Nery; Julia Moreira Pescarini; Anna Ramond; Carlos Antônio de Souza Teles Santos; Maria Yury Ichihara; Maria Lucia Fernandes Penna; Elizabeth B Brickley; Laura C Rodrigues; Liam Smeeth; Mauricio L Barreto; Susan Martins Pereira; Gerson Oliveira Penna
Journal:  PLoS Negl Trop Dis       Date:  2019-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.